<DOC>
	<DOCNO>NCT00021138</DOCNO>
	<brief_summary>RATIONALE : Computer-assisted scheduling nicotine inhaler use may effective method help people stop smoking . PURPOSE : Randomized cinical trial compare effectiveness computer-assisted scheduling nicotine inhaler use self-scheduled nicotine inhaler use participant plan stop smoking .</brief_summary>
	<brief_title>Computer-Assisted Scheduling Nicotine Inhaler Use Participants Who Plan Stop Smoking</brief_title>
	<detailed_description>OBJECTIVES : I . Determine effect program length inhaler use compliance , latency smoking relapse , gradual cessation inhaler use participant use computer-assisted program schedule nicotine inhaler dose smoke cessation . II . Compare fast slow paced version computer-assisted schedule nicotine inhaler use versus ad libitum nicotine inhaler use , term smoke cessation rate , participant . III . Compare dose condition , term adherence , initial dosing level , successful tapering effect , participant . OUTLINE : This randomize study . Participants randomize one three arm . All participant monitor period cigarette smoke 7 day press data input button hand-held computer every time smoke . Arm I : Participants begin use nicotine inhaler accord dose instruction come monitor inhaler usage hand-held computer . Arm II : Participants prompt hand-held computer use nicotine inhaler base prior smoke habit . When prompt , participant use nicotine inhaler comfortable rate 20 minute . The computer prompt participant fixed frequency duration inhaler use 3 week taper frequency duration 3-5 week . Arm III : Participants prompt hand-held computer use nicotine inhaler arm II . The computer prompt participant fixed frequency duration inhaler use 12 week taper frequency duration 3-5 week . Participants keep weekly diary average number cigarette smoke , average number inhaler session , average length session . Participants also record date 24-hour smoking cessation relapse complete withdrawal symptom questionnaire . Participants follow 1 year . PROJECTED ACCRUAL : A total 480 participant accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Smoker daily smoke rate 15 40 cigarette per day least 2 year Willing quit smoking Willing use nicotine inhaler No concurrent use smokeless tobacco , pipe , cigar PATIENT CHARACTERISTICS : Age : 18 67 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : No liver disease Renal : No kidney disease Cardiovascular : No history heart disease No high blood pressure Other : No stomach ulcers No overactive thyroid Not pregnant nursing No plan become pregnant within next 6 month PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : No concurrent insulin Radiotherapy : Not specify Surgery : Not specify Other : At least 1 month since prior bupropion antidepressant At least 1 year since prior treatment substance abuse No concurrent nicotine replacement product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>67 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>small cell lung cancer</keyword>
	<keyword>esophageal cancer</keyword>
	<keyword>hypopharyngeal cancer</keyword>
	<keyword>laryngeal cancer</keyword>
	<keyword>nasopharyngeal cancer</keyword>
	<keyword>oropharyngeal cancer</keyword>
	<keyword>lip oral cavity cancer</keyword>
	<keyword>paranasal sinus nasal cavity cancer</keyword>
	<keyword>tongue cancer</keyword>
</DOC>